Q32 Bio
Price & Volume
Stats
See more52W Range | $1.34-$4.82 |
Market Cap | $56.1M |
Shares Short | 365,620 |
Financials
See moreRevenue (12 Mos) | -$14.6M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$26.3M |
Diluted EPS | -$3.40 |
News
See moreYahoo Finance • 10 days ago
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
Yahoo Finance • 3 months ago
BC-Most Active Stocks
Yahoo Finance • 3 months ago
Akebia Announces Establishment of Rare Kidney Disease Pipeline
Yahoo Finance • 4 months ago
Q32 Bio GAAP EPS of -$0.60 beats by $0.59
About
CEO | Ms. Jodie Pope Morrison |
CFO | Mr. Lee H. Kalowski M.B.A. |
Address | 830 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 26 |
